APA (7th ed.) Citation

JS, W., MR, M., G, Y., DJ, S., M, K., M, L., . . . P, M. (2025). Estimating Long-Term Survivorship Rates Among Patients With Resected Stage III/IV Melanoma: Analyses From CheckMate 238 and European Organization for Research and Treatment of Cancer 18071 Trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 43(8), 929. https://doi.org/10.1200/JCO.24.00237

Chicago Style (17th ed.) Citation

JS, Weber, Middleton MR, Yates G, Sharpe DJ, Kurt M, Lobo M, Moshyk A, Vanderpuye-Orgle J, and Mohr P. "Estimating Long-Term Survivorship Rates Among Patients With Resected Stage III/IV Melanoma: Analyses From CheckMate 238 and European Organization for Research and Treatment of Cancer 18071 Trials." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 43, no. 8 (2025): 929. https://doi.org/10.1200/JCO.24.00237.

MLA (9th ed.) Citation

JS, Weber, et al. "Estimating Long-Term Survivorship Rates Among Patients With Resected Stage III/IV Melanoma: Analyses From CheckMate 238 and European Organization for Research and Treatment of Cancer 18071 Trials." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 43, no. 8, 2025, p. 929, https://doi.org/10.1200/JCO.24.00237.